Clinical Trial Update: Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluated omega-3 fatty acids for advanced cancer patients with significant weight loss; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Leukemia, Lymphoma | Phase 1, Phase 2 | Status: COMPLETED